Abundance- and activity-based proteomics in platelet biology

Current Proteomics

Volumn 8, Issue 3, 2011, Pages 216-228

  Holly, Stephen P ^a   Chen, Xian ^a,b   Parise, Leslie V ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

ABPP; Biomarker; Cancer; Library; Mass spectrometry; Platelet; Proteome; Rat

Indexed keywords

AMS 1; AMS 2; AMS 3; ANTINEOPLASTIC AGENT; ARYLACETAMIDE DEACETYLASE LIKE 1; BETA ACTIN; C REACTIVE PROTEIN; CREATINE KINASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE OMEGA 1; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK PROTEIN; HYDROLASE; INITIATION FACTOR 4A; INTEGRIN; INTEGRIN ALPHAIIB BETA3; LYSOPHOSPHATIDIC ACID; MELANOMA ANTIGEN; MJE 3; MYOGLOBIN; MYOSIN; MYOSIN 9; PROTEIN KINASE FYN; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; SEPRASE; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOCYTE ACTIVATING FACTOR; TROPONIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACTIVITY BASED PROTEIN PROFILING; ANALYTIC METHOD; ATHEROSCLEROSIS; BREAST CANCER; CANCER INHIBITION; CARDIOVASCULAR DISEASE; CELL CYCLE REGULATION; CELL DENSITY; CELLULAR DISTRIBUTION; DIAGNOSTIC TEST; DRUG TARGETING; FLUORESCENCE ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; INFLAMMATION; LIQUID CHROMATOGRAPHY; MALIGNANT NEOPLASTIC DISEASE; MEGAKARYOCYTE; MELANOMA; MOLECULAR PROBE; NONHUMAN; OSTEOARTHRITIS; OVARY CANCER; PANCREAS CANCER; PRECIPITATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEOMICS; REVIEW; SEPARATION TECHNIQUE; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

RATTUS; VERTEBRATA;

EID: 80052838794     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016411797247512     Document Type: Review

References (52)

1. Andonegui, G.; Kerfoot, S. M.; McNagny, K.; Ebbert, K. V.; Patel, K. D. and Kubes, P. Platelets express functional Toll-like receptor- 4. Blood, 2005, 106(7), 2417-2423.
2. Clark, S. R.; Ma, A. C.; Tavener, S. A.; McDonald, B.; Goodarzi, Z.; Kelly, M. M.; Patel, K. D.; Chakrabarti, S.; McAvoy, E.; Sinclair, G. D.; Keys, E. M.; Allen-Vercoe, E.; Devinney, R.; Doig, C. J.; Green, F. H. and Kubes, P. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med., 2007, 13(4), 463-469.
3. Trikha, M. and Nakada, M. T. Platelets and cancer: implications for antiangiogenic therapy. Semin. Thromb. Hemost., 2002, 28(1), 39-44.
4. Lesurtel, M.; Graf, R.; Aleil, B.; Walther, D. J.; Tian, Y.; Jochum, W.; Gachet, C.; Bader, M. and Clavien, P. A. Platelet-derived serotonin mediates liver regeneration. Science, 2006, 312(5770), 104-107.
5. Gnatenko, D. V.; Perrotta, P. L. and Bahou, W. F. Proteomic approaches to dissect platelet function: Half the story. Blood, 2006, 108(13), 3983-3991.
6. Macaulay, I. C.; Carr, P.; Gusnanto, A.; Ouwehand, W. H.; Fitzgerald, D. and Watkins, N. A. Platelet genomics and proteomics in human health and disease. J. Clin. Invest., 2005, 115(12), 3370-3377.
7. Piersma, S. R.; Broxterman, H. J.; Kapci, M.; de Haas, R. R.; Hoekman, K.; Verheul, H. M. and Jimenez, C. R. Proteomics of the TRAP-induced platelet releasate. J. Proteomics, 2009, 72(1), 91-109.
8. Garcia, B. A.; Smalley, D. M.; Cho, H.; Shabanowitz, J.; Ley, K. and Hunt, D. F. The platelet microparticle proteome. J. Proteome Res., 2005, 4(5), 1516-1521.
9. Schulz, C.; Leuschen, N. V.; Frohlich, T.; Lorenz, M.; Pfeiler, S.; Gleissner, C. A.; Kremmer, E.; Kessler, M.; Khandoga, A. G.; Engelmann, B.; Ley, K.; Massberg, S. and Arnold, G. J. Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood, 2010, 115(20), 4102-4110.
10. Elias, J. E.; Haas, W.; Faherty, B. K. and Gygi, S. P. Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat. Methods, 2005, 2(9), 667-675.
11. Yu, Y.; Leng, T.; Yun, D.; Liu, N.; Yao, J.; Dai, Y.; Yang, P. and Chen, X. Global analysis of the rat and human platelet proteomethe molecular blueprint for illustrating multi-functional platelets and cross-species function evolution. Proteomics, 2010, 10(13), 2444-2457.
12. Kuchay, S. M. and Chishti, A. H. Calpain-mediated regulation of platelet signaling pathways. Curr. Opin. Hematol., 2007, 14(3), 249-254.
13. Weyrich, A. S.; Dixon, D. A.; Pabla, R.; Elstad, M. R.; McIntyre, T. M.; Prescott, S. M. and Zimmerman, G. A. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc. Natl. Acad. Sci. USA, 1998, 95(10), 5556-5561.
14. Ishihama, Y.; Oda, Y.; Tabata, T.; Sato, T.; Nagasu, T.; Rappsilber, J. and Mann, M. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell Proteomics, 2005, 4(9), 1265-1272.
15. Kanehisa, M.; Goto, S.; Hattori, M.; Aoki-Kinoshita, K. F.; Itoh, M.; Kawashima, S.; Katayama, T.; Araki, M. and Hirakawa, M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res., 2006, 34(Database issue), D354-D357.
16. Chen, F.; Mackey, A. J.; Stoeckert, C. J., Jr. and Roos, D. S. OrthoMCL- DB: querying a comprehensive multi-species collection of ortholog groups. Nucleic Acids Res. 2006, 34(Database issue), D363-D368.
17. Cravatt, B. F.; Wright, A. T. and Kozarich, J. W. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu. Rev. Biochem., 2008, 77, 383-414.
18. Paulick, M. G. and Bogyo, M. Application of activity-based probes to the study of enzymes involved in cancer progression. Curr. Opin. Genet. Dev., 2008, 18(1), 97-106.
19. Adam, G. C.; Sorensen, E. J. and Cravatt, B. F. Trifunctional chemical probes for the consolidated detection and identification of enzyme activities from complex proteomes. Mol. Cell Proteomics, 2002, 1(10), 828-835.
20. Kidd, D.; Liu, Y. and Cravatt, B. F. Profiling serine hydrolase activities in complex proteomes. Biochemistry, 2001, 40(13), 4005-4015.
21. Liu, Y.; Patricelli, M. P. and Cravatt, B. F. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA, 1999, 96(26), 14694-14699.
22. Sadaghiani, A. M.; Verhelst, S. H.; Gocheva, V.; Hill, K.; Majerova, E.; Stinson, S.; Joyce, J. A. and Bogyo, M. Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl- based inhibitors of papain-family cysteine proteases. Chem. Biol., 2007, 14(5), 499-511.
23. Speers, A. E.; Adam, G. C. and Cravatt, B. F. Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition. J. Am. Chem. Soc., 2003, 125(16), 4686-4687.
24. Speers, A. E. and Cravatt, B. F. Profiling enzyme activities in vivo using click chemistry methods. Chem. Biol., 2004, 11(4), 535-546.
25. Kolb, H. C. and Sharpless, K. B. The growing impact of click chemistry on drug discovery. Drug Discov. Today, 2003, 8(24), 1128-1137.
26. Adam, G. C.; Sorensen, E. J. and Cravatt, B. F. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat. Biotechnol., 2002, 20(8), 805-809.
27. Speers, A. E. and Cravatt, B. F. A tandem orthogonal proteolysis strategy for high-content chemical proteomics. J. Am. Chem. Soc., 2005, 127(28), 10018-10019.
28. Wong, J. W.; McRedmond, J. P. and Cagney, G. Activity profiling of platelets by chemical proteomics. Proteomics, 2009, 9(1), 40-50.
29. Obergfell, A.; Eto, K.; Mocsai, A.; Buensuceso, C.; Moores, S. L.; Brugge, J. S.; Lowell, C. A. and Shattil, S. J. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. J. Cell Biol., 2002, 157(2), 265-275.
30. Verma, S.; Wang, C. H.; Li, S. H.; Dumont, A. S.; Fedak, P. W.; Badiwala, M. V.; Dhillon, B.; Weisel, R. D.; Li, R. K.; Mickle, D. A. and Stewart, D. J. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation, 2002, 106(8), 913-919.
31. Zwaka, T. P.; Hombach, V. and Torzewski, J. C-reactive proteinmediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation, 2001, 103(9), 1194-1197.
32. Sabatine, M. S.; Morrow, D. A.; de Lemos, J. A.; Gibson, C. M.; Murphy, S. A.; Rifai, N.; McCabe, C.; Antman, E. M.; Cannon, C. P. and Braunwald, E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation, 2002, 105(15), 1760-1763.
33. Seo, D.; Wang, T.; Dressman, H.; Herderick, E. E.; Iversen, E. S.; Dong, C.; Vata, K.; Milano, C. A.; Rigat, F.; Pittman, J.; Nevins, J. R.; West, M. and Goldschmidt-Clermont, P. J. Gene expression phenotypes of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2004, 24(10), 1922-1927.
34. Jessani, N.; Liu, Y.; Humphrey, M. and Cravatt, B. F. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc. Natl. Acad. Sci. USA, 2002, 99(16), 10335-10340.
35. Chiang, K. P.; Niessen, S.; Saghatelian, A. and Cravatt, B. F. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem. Biol., 2006, 13(10), 1041-1050.
36. Greenbaum, D.; Medzihradszky, K. F.; Burlingame, A. and Bogyo, M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol., 2000, 7(8), 569-581.
37. Vasiljeva, O.; Papazoglou, A.; Kruger, A.; Brodoefel, H.; Korovin, M.; Deussing, J.; Augustin, N.; Nielsen, B. S.; Almholt, K.; Bogyo, M.; Peters, C. and Reinheckel, T. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res., 2006, 66(10), 5242-5250.
38. Borodovsky, A.; Ovaa, H.; Kolli, N.; Gan-Erdene, T.; Wilkinson, K. D.; Ploegh, H. L. and Kessler, B. M. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol., 2002, 9(10), 1149-1159.
39. Ovaa, H.; Kessler, B. M.; Rolen, U.; Galardy, P. J.; Ploegh, H. L. and Masucci, M. G. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. Proc. Natl. Acad. Sci. USA, 2004, 101(8), 2253-2258.
40. Rolen, U.; Kobzeva, V.; Gasparjan, N.; Ovaa, H.; Winberg, G.; Kisseljov, F. and Masucci, M. G. Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines. Mol. Carcinog., 2006, 45(4), 260-269.
41. Salisbury, C. M. and Cravatt, B. F. Activity-based probes for proteomic profiling of histone deacetylase complexes. Proc. Natl. Acad. Sci. USA, 2007, 104(4), 1171-1176.
42. Milner, J. M.; Elliott, S. F. and Cawston, T. E. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. Arthritis Rheum., 2001, 44(9), 2084-2096.
43. Milner, J. M.; Kevorkian, L.; Young, D. A.; Jones, D.; Wait, R.; Donell, S. T.; Barksby, E.; Patterson, A. M.; Middleton, J.; Cravatt, B. F.; Clark, I. M.; Rowan, A. D. and Cawston, T. E. Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis. Arthritis. Res. Ther., 2006, 8(1), R23.
44. Evans, M. J.; Saghatelian, A.; Sorensen, E. J. and Cravatt, B. F. Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling. Nat. Biotechnol., 2005, 23(10), 1303-1307.
45. Liu, S.; Widom, J.; Kemp, C. W.; Crews, C. M. and Clardy, J. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science, 1998, 282(5392), 1324-1327.
46. Leung, D.; Hardouin, C.; Boger, D. L. and Cravatt, B. F. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat. Biotechnol., 2003, 21(6), 687-691.
47. Li, W.; Blankman, J. L. and Cravatt, B. F. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. J. Am. Chem. Soc., 2007, 129(31), 9594-9595.
48. Saghatelian, A.; Jessani, N.; Joseph, A.; Humphrey, M. and Cravatt, B. F. Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl. Acad. Sci. USA, 2004, 101(27), 10000-10005.
49. Angiolillo, D. J.; Fernandez-Ortiz, A.; Bernardo, E.; Ramirez, C.; Sabate, M.; Jimenez-Quevedo, P.; Hernandez, R.; Moreno, R.; Escaned, J.; Alfonso, F.; Banuelos, C.; Costa, M. A.; Bass, T. A. and Macaya, C. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention. Am. J. Cardiol., 2006, 97(1), 38-43.
50. Angiolillo, D. J.; Fernandez-Ortiz, A.; Bernardo, E.; Alfonso, F.; Macaya, C.; Bass, T. A. and Costa, M. A. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J. Am. Coll. Cardiol., 2007, 49(14), 1505-1516.
51. Gum, P. A.; Kottke-Marchant, K.; Welsh, P. A.; White, J. and Topol, E. J. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J. Am. Coll. Cardiol., 2003, 41(6), 961-965.
52. Wright, A. T.; Song, J. D. and Cravatt, B. F. A suite of activitybased probes for human cytochrome P450 enzymes. J. Am. Chem. Soc., 2009, 131(30), 10692-10700.